Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1996
12/12/1996WO1996039391A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996WO1996039390A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996WO1996039385A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
12/12/1996WO1996039383A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
12/12/1996WO1996039382A1 Urea derivatives as 5-ht antagonists
12/12/1996WO1996039374A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
12/12/1996WO1996039169A1 Methods and compositions for healing and repair of connective tissue attachment
12/12/1996WO1996039164A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
12/12/1996WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996WO1996039151A1 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
12/12/1996WO1996039150A1 Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
12/12/1996WO1996039149A1 Anhydrous alendronate monosodium salt formulations
12/12/1996WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/12/1996WO1996039138A1 Methods for minimizing bone loss
12/12/1996WO1996039050A2 Therapeutic system for dietary health management
12/12/1996WO1996039035A1 Myogenic differentiation of human mesenchymal stem cells
12/12/1996WO1996035788A3 Kunitz type protease inhibitors
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996WO1996030055A3 Radiolabeled peptides for diagnosis and therapy
12/12/1996WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
12/12/1996WO1996011951A3 Keratinocyte growth factor analogs
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223585A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223421A1 Methods for enhancement of protective immune responses
12/12/1996CA2223400A1 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
12/12/1996CA2223393A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223239A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2223102A1 Therapeutic system for dietary health management
12/12/1996CA2223055A1 Methods for minimizing bone loss
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2221844A1 Disodium alendronate formulations
12/12/1996CA2221842A1 Alpha 1a adrenergic receptor antagonists
12/12/1996CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221416A1 Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/11/1996EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
12/11/1996EP0747393A1 Thiazolo benzazepine containing dual action inhibitors
12/11/1996EP0747392A1 1,2-Diazepine containing dual action inhibitors
12/11/1996EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747379A1 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia
12/11/1996EP0747378A1 Dihydropyridine NPY antagonists
12/11/1996EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747357A2 Dihydropyridine NPY antagonists: piperidine derivatives
12/11/1996EP0747356A1 Dihydropyridine NPY antagonists: piperazine derivatives
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747347A1 RARy-specific retinobenzoic acid derivatives
12/11/1996EP0747346A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/11/1996EP0747345A2 Ethylamido fluorenes and improved method of making same
12/11/1996EP0747054A2 Methods for minimizing bone loss
12/11/1996EP0747052A2 Methods of modulating NF-KB transcription factor
12/11/1996EP0747051A2 Methods of inducing BEF-1 transcription factor
12/11/1996EP0747050A1 Pharmaceutical compositions containing irbesartan
12/11/1996EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
12/11/1996EP0747042A1 Compositions containing azole derivatives for topical application to skin
12/11/1996EP0746612A1 Synthetic polynucleotides
12/11/1996EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/11/1996EP0746565A1 Novel bombesin-related peptides
12/11/1996EP0746564A1 4-n-substituted sialic acids and their sialosides
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746556A1 Tricyclic compounds having affinity for the 5-ht1a receptor
12/11/1996EP0746551A1 Optically pure 4-aryl-2-hydroxytetronic acids
12/11/1996EP0746545A1 Nipecotic acid derivatives as antithrombic compounds
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0746326A1 Oligomeric compounds having nitrogen-containing linkages
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996EP0746323A1 Inhibitors of phosphoinositide-specific phospholipase c
12/11/1996EP0746316A1 Therapeutic guanidines
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
12/11/1996EP0695305A4 Method of forming oligonucleotides
12/11/1996EP0533840B1 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
12/11/1996EP0521080B1 Synergistic compositions
12/11/1996CN1137794A 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137754A 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/11/1996CN1137402A Aconite oral liquor and preparation method thereof
12/10/1996US5583222 Antiinflammatory agents for treatment of skin disorders
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583220 Pyrole nitrogen-substituted texaphyrins
12/10/1996US5583160 Exposing cells to dimethyl sphingosine until preferential level of cell death has occured
12/10/1996US5583159 Treatment of internal radiation damage
12/10/1996US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives
12/10/1996US5583141 Heterocyclic compounds and their use as angiotensin antagonists
12/10/1996US5583130 Benzo-fused lactams promote release of growth hormone
12/10/1996US5583128 Contraception in female primates without affecting the menstrual cycle
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583101 S-nitroso amino acids
12/10/1996US5582832 Compositions for topical application to skin
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996CA2178548A1 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
1 ... 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 ... 1564